Longeveron Inc. (LGVN)
Data as of , from SEC Form 4 filings.
See up to 3 months of LGVN. The 7-day demo opens the 1M and 3M ranges and puts LGVN on your watchlist.
Start 7-day demoLatest LGVN insider trades
About Longeveron Inc. (LGVN)
Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.
- MIAMI, FL
- 38
- 2021
- XNAS
LGVN Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 12 | 1,696,000 | |
| Tax withholding / forfeiture | 5 | 10,415 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
LGVN insider transactions (Form 4)
3166 Form 4 filings on record, the earliest from Oct 3, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nirav S. Jhaveri - Officer | Tax withholding / forfeiture | Class A Common Stock | 742 footnote F1 | $2.59 | $2K | |
| ||||||
| Stephen H. Willard - Officer | Tax withholding / forfeiture | Class A Common Stock | 1,987 footnote F1 | $2.59 | $5K | |
| ||||||
| Nataliya Agafonova - Officer | Tax withholding / forfeiture | Class A Common Stock | 2,913 footnote F1 | $2.59 | $8K | |
| ||||||
| Paul T. Lehr - Officer | Tax withholding / forfeiture | Class A Common Stock | 2,253 footnote F1 | $2.59 | $6K | |
| ||||||
| Devin Blass - Officer | Tax withholding / forfeiture | Class A Common Stock | 2,520 footnote F1 | $2.59 | $7K | |
| ||||||
| Nirav S. Jhaveri - Officer | Grant or award | Class A Common Stock | 300,000 footnote F1 | $0.00 | - | |
| ||||||
| Paul T. Lehr - Officer | Grant or award | Class A Common Stock | 286,000 footnote F1 | $0.00 | - | |
| ||||||
| Roger Joseph Hajjar - Director | Grant or award | Class A Common Stock | 36,000 footnote F1 | $0.00 | - | |
| ||||||
| Rock Soffer - Director | Grant or award | Class A Common Stock | 36,000 footnote F1 | $0.00 | - | |
| ||||||
| George A. Paletta Jr. - Director | Grant or award | Class A Common Stock | 36,000 footnote F1 | $0.00 | - | |
| ||||||
| Leah Rush Cann - Director | Grant or award | Class A Common Stock | 36,000 footnote F1 | $0.00 | - | |
| ||||||
| Ursula Ungaro - Director | Grant or award | Class A Common Stock | 36,000 footnote F1 | $0.00 | - | |
| ||||||
| Arjun Jj Desai - Director | Grant or award | Class A Common Stock | 36,000 footnote F1 | $0.00 | - | |
| ||||||
| Devin Blass - Officer | Grant or award | Class A Common Stock | 286,000 footnote F1 | $0.00 | - | |
| ||||||
| Deborah Ascheim - Director | Grant or award | Class A Common Stock | 36,000 footnote F1 | $0.00 | - | |
| ||||||
| Nataliya Agafonova - Officer | Grant or award | Class A Common Stock | 286,000 footnote F1 | $0.00 | - | |
| ||||||
 Joshua Hare - Officer | Grant or award | Class A Common Stock | 286,000 footnote F1 | $0.00 | - | |
| ||||||
| Joshua Hare - Officer | Grant or award | Class B Common Stock | 600,000 footnote F1 | $0.00 | - | |
| Joshua Hare - Officer | Grant or award | Stock Option (right to buy) | 400,000 | $0.00 | - | |
| ||||||
| Stephen H. Willard - Officer | Tax withholding / forfeiture | Class A Common Stock | 18,046 footnote F1 | $7.29 | $13K | |
| ||||||
 Lisa Locklear - Officer | Tax withholding / forfeiture | Class A Common Stock | 22,505 footnote F1 | $7.29 | $16K | |
| ||||||
| Nataliya Agafonova - Officer | Tax withholding / forfeiture | Class A Common Stock | 22,505 footnote F1 | $7.29 | $16K | |
| ||||||
| Devin Blass - Officer | Tax withholding / forfeiture | Class A Common Stock | 15,808 footnote F1 | $7.29 | $12K | |
| ||||||
| Paul T. Lehr - Officer | Tax withholding / forfeiture | Class A Common Stock | 13,143 footnote F1 | $7.29 | $10K | |
| ||||||
| Paul T. Lehr - Officer | Grant or award | Class A Common Stock | 250,000 footnote F1 | $0.00 | - | |
| ||||||
| Stephen H. Willard - Officer | Grant or award | Class A Common Stock | 500,000 footnote F1 | $0.00 | - | |
| ||||||
| Devin Blass - Officer | Grant or award | Class A Common Stock | 250,000 footnote F1 | $0.00 | - | |
| ||||||
| Nataliya Agafonova - Officer | Grant or award | Class A Common Stock | 250,000 footnote F1 | $0.00 | - | |
| ||||||
| Lisa Locklear - Officer | Grant or award | Class A Common Stock | 250,000 footnote F1 | $0.00 | - | |
| ||||||
| Paul T. Lehr - Officer | Tax withholding / forfeiture | Class A Common Stock | 5,611 footnote F1 | $11.20 | $6K | |
| ||||||
| Nataliya Agafonova - Officer | Tax withholding / forfeiture | Class A Common Stock | 13,145 footnote F1 | $11.20 | $15K | |
| ||||||
LGVN insider trading FAQ
What is the latest insider trade for LGVN?
Longeveron Inc. (LGVN) had 17 insider filings in the last 90 days, with the most recent on 2026-10-05. The full record for LGVN runs to 66 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying LGVN stock?
No insider purchases of LGVN were filed in the last 90 days. 4 purchases are on record for this company.
How many insiders are selling LGVN stock?
No insider sales of LGVN were filed in the last 90 days. 1 sale is on record for this company.
Where can I see LGVN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects LGVN Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Nirav S. Jhaveri view on EDGAR
- - Stephen H. Willard view on EDGAR
- - Nataliya Agafonova view on EDGAR
- - Paul T. Lehr view on EDGAR
- - Devin Blass view on EDGAR
- - Nirav S. Jhaveri view on EDGAR
- - Paul T. Lehr view on EDGAR
- - Roger Joseph Hajjar view on EDGAR
- - Rock Soffer view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where LGVN's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow LGVN with a 7-day demo
- LGVN on your watchlist
- Every LGVN Form 4 filing on record
- Up to 3 months of LGVN price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
